Explore whether biosimilars work as well as reference biologics. We analyze clinical data, safety profiles, and patient experiences to answer key questions about effectiveness and cost.
Continue Reading
Learn how to use the FDA Orange Book and Purple Book to verify drug safety, spot withdrawn medications, and check biosimilar equivalence. Essential for pharmacists, clinicians, and patients.
Continue Reading
In the U.S., only certain biosimilars are designated as interchangeable by the FDA, allowing pharmacists to swap them for brand-name biologics without a doctor’s approval. Learn how it works, which ones qualify, and why state laws make it complicated.
Continue Reading
